http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-922258-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc2f7134efa50484bb359fda73782848
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-69
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-69
filingDate 1961-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1963-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-922258-A
titleOfInvention Phosphoric acid esters of substituted fluoroalkanols and process for their manufacture
abstract The invention comprises compounds of the formula <FORM:0922258/IV(a)/1> where R1 is hydrogen or alkyl of 1-5 carbon atoms, R2 is a free or esterified carboxyl group, a carboxamido group or an ether group, and n is 0 or 1; their salts, and their preparation by reacting a compound <FORM:0922258/IV(a)/2> where R2 is a free or functionally modified carboxyl group or an ether group, with a reactive derivative of phosphoric acid, and if desired, if necessary after conversion of the product into the free phosphoric acid ester, converting into a salt. Suitable reactants are phosphoric acid anhydrides, such as polyphosphoric or pyrophosphoric acids, halides, such as POCl3, and esters, such as diaryl halophosphates. If R1 in the reactant is -CN it is converted by the reaction to -COOH or -CONH2. Examples prepare the calcium salts of (1) a -phosphoroxy-b -fluorolactic acid methyl ester, (2) 3-phosphoroxy-4-fluorobutyramide, (3) 3-phosphoroxy-4-fluorobutyric acid, (4) 2-carboxamido-2-phosphoroxy-3-fluoropropane and (5) 1-guaiacyloxy- 2-phosphoroxy- 3-fluoropropane. The compounds of the invention are useful as pharmaceutical chemicals, especially for caries-inhibiting purposes (see Group VI). 3-Hydroxy-4-fluorobutyronitrile is prepared by reacting 1-chloro-2-hydroxy-3-fluoropropane with KCN in aqueous ethanol. Fluoroacetone cyanohydrin is obtained by addition of HCN to fluoroacetone. 1-Guaiacyloxy- 2-hydroxy- 3-fluoropropane is obtained by reacting guaiacol sodium salt with 1-chloro-2-hydroxy-3-fluoropropane, or by reacting guaiacol with epifluorohydrin. b -Fluorolactic acid methyl ester is obtained by esterifying the acid with diazomethane.ALSO:Pharmaceutical preparations, especially for the care of the teeth, comprise a compound <FORM:0922258/VI/1> where R1 is hydrogen or alkyl of 1-5 carbon atoms, R2 is a free or esterified carboxyl group, a carboxamido group or an ether group and n is 0 or 1 or a salt thereof (see Group IV (b)) in admixture or conjunction with a pharmaceutically suitable carrier, e.g. a toothpaste mixture. Suitable carriers are gelatin, cholesterol, lactose, starch, magnesium stearate, talc, vegetable oils, benzyl alcohol, gums, polyalkylene glycols, and petroleum jelly. The compositions may be made up as tablets, dragees, powders, ointments, creams, solutions, suspensions or emulsions. Preserving, stabilising, wetting or emulsifying agents may also be present.
priorityDate 1960-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420174926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449166698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424523216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70053666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10418

Total number of triples: 49.